Human respiratory syncytial virus and other viral infections in infants receiving palivizumab

BACKGROUND: Palivizumab is a humanized monoclonal antibody that prevents severe human respiratory syncytial virus (HRSV) infections. OBJECTIVES: We determined the etiology of respiratory viral infections in palivizumab recipients, and monitored the clinical outcome and HRSV genotype in HRSV-infected...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Virol
Main Authors: Boivin, Guy, Caouette, Georges, Frenette, Line, Carbonneau, Julie, Ouakki, Manale, De Serres, Gaston
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7172843/
https://ncbi.nlm.nih.gov/pubmed/18164233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2007.11.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados